McGill University Department of Oncology / McGill University Health Centre

Montreal, Quebec H4A 3J1

0 studies enrolling now · 1 studies all time

What they study most

Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer — Completed